UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030804
Receipt number R000035175
Scientific Title The study of new bone substitute (AFFINOS) in bone osteoconductivity: bone microstructure analysis using high resolution CT
Date of disclosure of the study information 2018/01/15
Last modified on 2022/06/30 11:38:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of new bone substitute (AFFINOS) in bone osteoconductivity: bone microstructure analysis using high resolution CT

Acronym

The study of new bone substitutes (AFFINOS) in bone osteoconductivity

Scientific Title

The study of new bone substitute (AFFINOS) in bone osteoconductivity: bone microstructure analysis using high resolution CT

Scientific Title:Acronym

The study of new bone substitutes (AFFINOS) in bone osteoconductivity

Region

Japan


Condition

Condition

Knee osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the bone regeneration of grafted bone substitute by using HR-pQCT

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Bone mineral density, bone microarchitecture, bone strength estimated using micro-finite element analysis

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Bioresorbable bone-graft substitute (AFFINOS)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient with knee osteoarthritis, scheduled to have tibial osteotomy
A written informed consent for the participation in the study

Key exclusion criteria

Patients judged to be inadequate for this study by investigators

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Osaki

Organization

Nagasaki University graduate school of biomedical sciences

Division name

Department of orthopaedic surgery

Zip code

8528501

Address

1-7-1 Sakamoto, Nagasaki, Japan

TEL

095-819-7321

Email

mosaki@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Ko
Middle name
Last name Chiba

Organization

Nagasaki University Hospital

Division name

Department of orthopaedic surgery

Zip code

8528501

Address

1-7-1 Sakamoto, Nagasaki, Japan

TEL

095-819-7321

Homepage URL


Email

kohchiba@estate.ocn.ne.jp


Sponsor or person

Institute

Nagasaki University Hospital
Department of orthopaedic surgery

Institute

Department

Personal name



Funding Source

Organization

Kuraray Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Clinical Research Review Board in Nagasaki University

Address

1-7-1 Sakamoto, Nagasaki-shi, Nagasaki-ken

Tel

095-819-7229

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

5

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Data analysis is delayed.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 15 Day

Date of IRB

2018 Year 01 Month 16 Day

Anticipated trial start date

2018 Year 01 Month 16 Day

Last follow-up date

2020 Year 07 Month 31 Day

Date of closure to data entry

2021 Year 07 Month 31 Day

Date trial data considered complete

2021 Year 07 Month 31 Day

Date analysis concluded

2021 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 01 Month 14 Day

Last modified on

2022 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035175


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name